Chat with us
Research Assistance
Online
  • Please enter your first name.

Italy Infectious Disease Molecular Diagnostics Market Size & Outlook

The infectious disease molecular diagnostics market in Italy is expected to reach a projected revenue of US$ 427.0 million by 2030. A compound annual growth rate of 2.4% is expected of Italy infectious disease molecular diagnostics market from 2025 to 2030.

  • Clinical Diagnostics
    • In Vitro Diagnostics
      • Infectious Disease Molecular Diagnostics Market Outlook
Revenue, 2024 (US$M)
$370.8
Forecast, 2030 (US$M)
$427.0
CAGR, 2025 - 2030
2.4%
Report Coverage
Italy

Italy Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

Italy Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the infectious disease molecular diagnostics market

Every figure cited from GVR research

Italy infectious disease molecular diagnostics market highlights

  • The Italy infectious disease molecular diagnostics market generated a revenue of USD 370.8 million in 2024 and is expected to reach USD 427.0 million by 2030.
  • The Italy market is expected to grow at a CAGR of 2.4% from 2025 to 2030.
  • In terms of segment, reagents product was the largest revenue generating product in 2024.
  • Others Product is the most lucrative product segment registering the fastest growth during the forecast period.

Infectious disease molecular diagnostics market data book summary

Market revenue in 2024USD 370.8 million
Market revenue in 2030USD 427.0 million
Growth rate2.4% (CAGR from 2025 to 2030)
Largest segmentReagents product
Fastest growing segmentOthers Product
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments Product, Reagents Product, Others Product
Key market players worldwideAbbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp

Other key industry trends

  • In terms of revenue, Italy accounted for 2.3% of the global infectious disease molecular diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK infectious disease molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 716.2 million by 2030.

Increasing demand for rapid diagnostic procedures and rising prevalence of infectious diseases in the country are driving growth of infectious diseases molecular diagnostics market in Italy. Wide network of manufacturers & distributors in the country are providing essential instruments, kits, & reagents for molecular diagnostics, which is likely to provide a growth platform for this market. 

R&D activities are also expected to increase in Italy due to various funds & grants offered for basic research by government & nongovernment organizations. Favorable government initiatives and development of independent diagnostic centers are expected to further boost market growth during the forecast period. 

These local market players are receiving EUA for their newly developed molecular tests during the pandemic, which can be utilized by hospital laboratories to obtain quick test results. For instance, in March 2020, DiaSorin Molecular LLC received EUA from the U.S. FDA for Simplexa COVID-19 Direct kit that rapidly detects coronavirus in an hour.

No credit card required*

Publish Date: Mar 04, 2025

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Disease Molecular Diagnostics Market Companies

NameProfile# EmployeesHQWebsite
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
Becton Dickinson & CoView profile 73,0001 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880www.bd.com
BioMerieux SAView profile 13,982Marcy l’Etoile, Lyon, France, 69280www.biomerieux.com
Siemens Healthineers AG ADRView profile 71,400Siemensstr. 3, Forchheim, BY, Germany, 91301www.siemens-healthineers.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Agilent Technologies IncView profile 17,7005301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051www.agilent.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com

Italy Infectious Disease Molecular Diagnostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Infectious Disease Molecular Diagnostics Market Outlook will help companies and investors design strategic landscapes.


Reagents Product was the largest segment with a revenue share of 67.64% in 2024.

Horizon Databook has segmented the Italy infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.




Increasing demand for rapid diagnostic procedures and rising prevalence of infectious diseases in the country are driving growth of infectious diseases molecular diagnostics market in Italy. Wide network of manufacturers & distributors in the country are providing essential instruments, kits, & reagents for molecular diagnostics, which is likely to provide a growth platform for this market. 

R&D activities are also expected to increase in Italy due to various funds & grants offered for basic research by government & nongovernment organizations. Favorable government initiatives and development of independent diagnostic centers are expected to further boost market growth during the forecast period. 

These local market players are receiving EUA for their newly developed molecular tests during the pandemic, which can be utilized by hospital laboratories to obtain quick test results. For instance, in March 2020, DiaSorin Molecular LLC received EUA from the U.S. FDA for Simplexa COVID-19 Direct kit that rapidly detects coronavirus in an hour.

  • Italy Infectious Disease Molecular Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Instruments Product
    • Reagents Product
    • Services Product
  • Italy Infectious Disease Molecular Diagnostics Market Test location Outlook (Revenue, USD Million , 2018-2030)
    • Hospitals
    • Clinics
    • Diagnostics Laboratories
    • Research Institutes
  • Italy Infectious Disease Molecular Diagnostics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Polymerase Chain Reaction (PCR)
    • In Situ Hybridization
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Chips and microarrays
    • Mass spectrometry
    • Transcription Mediated Amplification
    • Others
  • Italy Infectious Disease Molecular Diagnostics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Respiratory Diseases
    • Tuberculosis
    • Meningitis
    • Gastrointestinal Tract Infections
    • HPV
    • Sexually Transmitted Infection
    • Sepsis
    • Drug Resistance Disease
    • Others Application

Reasons to subscribe to Infectious Disease Molecular Diagnostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Infectious Disease Molecular Diagnostics Market Outlook databook

  • Our clientele includes a mix of Infectious Disease Molecular Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Italy Infectious Disease Molecular Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Infectious Disease Molecular Diagnostics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Italy Infectious Disease Molecular Diagnostics Market, 2018-2030 (US$M)

No Access Stack Chart

Italy infectious disease molecular diagnostics market statistics, by product, 2018-2030 (US$M)

No Access Pie Chart

Italy infectious disease molecular diagnostics market statistics, by product, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more